{
  "retracted": false,
  "timestamp": 1550188800000,
  "updates": [
    {
      "timestamp": 1585084763663,
      "identifier": {
        "doi": "10.1158/1078-0432.ccr-18-4267"
      },
      "type": "correction"
    }
  ],
  "identifier": {
    "doi": "10.1158/1078-0432.ccr-16-2287"
  },
  "publisher": "American Association for Cancer Research (AACR)",
  "title": "Correction: HER2-Overexpressing Breast Cancers Amplify FGFR Signaling upon Acquisition of Resistance to Dual Therapeutic Blockade of HER2"
}
